Endoscopic Devices - Indonesia | Statista Market Forecast

In Indonesia, revenue in the Endoscopic Devices market market is projected to reach US$124.80m in 2024.
The revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 8.53%, which will result in a market volume of US$187.90m by 2029.
In a global context, most revenue will be generated the United States, with a figure of US$10.39bn in 2024.
Indonesia's healthcare sector is increasingly adopting endoscopic devices, driven by a growing emphasis on minimally invasive surgical techniques and improved patient outcomes.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Indonesia is experiencing moderate growth, influenced by factors such as advancements in minimally invasive procedures, increasing healthcare investments, and rising demand for efficient diagnostic solutions among medical professionals.

Customer preferences: Consumers in Indonesia are progressively favoring minimally invasive procedures, reflecting a cultural preference for faster recovery and less discomfort. This shift is accompanied by a growing awareness of the benefits of endoscopic techniques for diagnostics and treatment, particularly among urban populations. Additionally, demographic changes, such as an aging population and rising middle-class income levels, are driving demand for advanced medical technologies. The increasing emphasis on preventive healthcare is also shaping preferences, leading to a heightened interest in efficient and accurate diagnostic solutions.

Trends in the market: In Indonesia, the Endoscopic Devices Market within the Medical Devices sector is experiencing a notable shift towards minimally invasive surgical techniques. This trend is fueled by an increasing preference for procedures that promise quicker recovery times and reduced postoperative discomfort. Urban populations are becoming more aware of the advantages of endoscopic methods for both diagnostics and therapeutic interventions. Additionally, with an aging demographic and a burgeoning middle class, there's a rising demand for sophisticated medical technologies. The focus on preventive healthcare is enhancing the appeal of accurate and efficient diagnostic tools, prompting industry stakeholders to innovate and adapt to these evolving consumer needs.

Local special circumstances: In Indonesia, the Endoscopic Devices Market is shaped by a unique blend of cultural and geographical factors. The country's diverse population, with varying levels of healthcare access, drives a demand for cost-effective and efficient medical solutions. Additionally, the archipelagic geography often complicates logistics, prompting innovations in portable and user-friendly endoscopic devices. Culturally, there is a growing acceptance of modern medical practices, influenced by urbanization and increased health literacy, leading to an expanded interest in minimally invasive procedures that promise shorter hospital stays and faster recovery times.

Underlying macroeconomic factors: The Endoscopic Devices Market in Indonesia is significantly influenced by macroeconomic factors such as national economic growth, healthcare spending, and foreign investment. As Indonesia's economy continues to expand, increased disposable income allows for greater healthcare expenditure, facilitating access to advanced medical technologies. Additionally, government fiscal policies that prioritize healthcare infrastructure development and public health initiatives are fostering an environment conducive to market growth. Global trends, such as the rising demand for minimally invasive surgical procedures, align with local healthcare needs, further driving innovation and adoption of endoscopic devices.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.